SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy.

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults ...

Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...